Device Trial Radar · NCT07613931
Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment
Last checked: Nov 20, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
5
Planned (sponsor's estimate)
Start
Jul 9, 2026
Primary completion
Sep 2026
Study completion Sep 2026
Sponsor
- Lead sponsor
- Tactile MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 29, 2026
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this pilot study is to learn if a revised method of compression improves lymphatic function compared to the current method of compression. The main questions: • Does the revised method of compression improve lymph movement and lymphatic propulsion?
Conditions
- Lower Extremity Lymphedema
Interventions
Advanced pneumatic compression device (APCD)Device
Single APCD treatment session at visit 1
Advanced pneumatic compression device (APCD) with revised compression programmingDevice
APCD with revised compression programming will be single treatment session at visit 2
Indocyanine Green (IC-Green)Drug
Indocyanine Green dye will be used to assess primary endpoint
Primary outcomes
What the sponsor says the trial is designed to measure.
- Lymphatic anatomyTime frame: Before and after 60-minute treatment in clinic with APCD
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
UTHealth Houston (The University of Texas Health Science Center at Houston)
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.